Pharma Mfg & Export Biz Raising Funds In Ahmedabad

About Business

An India-based pharmaceutical group with over 7 years of experience, the business operates across pharmaceutical manufacturing, international exports, regulatory support, and emerging-market commercial operations through two entities under common ownership. The India-based parent company drives the group's manufacturing and export platform, while its wholly owned Nigeria subsidiary handles local product registrations, sales, distribution, and warehousing in the Nigerian market.

The business operates on a branded formulations and Contract Manufacturing (CMO/CDMO) model, offering two core services: marketing and distribution of its own branded products, and contract manufacturing and export of partner brands to their respective markets. Manufacturing is carried out through six third-party units with capabilities across multiple dosage forms, with a focus on chronic care segments including oncology and anti-diabetic therapies.

The product portfolio spans 250+ formulation dossiers with COPP, 24 registered pharmaceutical products, 14 registered nutraceuticals, and 12 Marketing Authorizations held directly by the group. An additional 13 products are currently under regulatory approval, and 50+ SKUs are in dossier preparation across 7 countries, including Stringent Regulatory Authority (SRA) markets. Products are in-licensed from USFDA- and EU GMP-certified manufacturing facilities. The group currently exports to 12+ countries through 18 global distribution partners, with a consolidated revenue of INR 50 crore in FY 2025–26.

The founder is a seasoned pharmaceutical entrepreneur with over 20 years of professional experience across healthcare, pharmaceutical manufacturing, exports and business development. He leads two complementary businesses: the first focused on pharmaceutical manufacturing and the domestic/franchise market in India, with an expanding export presence; and the second focused on pharmaceutical exports, global sourcing and business development, with a strong presence across international markets, particularly Africa and other regulated/semi-regulated markets. As Managing Director, he oversees the strategic direction, business growth and international expansion of both ventures, leveraging an integrated manufacturing-to-market approach.

Clientele type

They supply the domestic market as well as export to 12+ countries with 18 global partners. They also have a wholly owned subsidiary in Nigeria for distribution.

Premises

Their office is leased.

Asking Price Includes

The terms of the transaction will be discussed with potential investors.

Asking Price

INR 10.00 Cr

Minimum ticket size

INR 3.00 Cr

Reason

The funds will be used to expand the sales & distribution network, file new dossiers, and expand the team.